Skip to main content
. 2018 Jan-Mar;28(1):18–25. doi: 10.4103/jcecho.jcecho_63_17

Table 1.

The main clinical and echographic characteristics of the study population

Characteristics Value

Clinical characteristics
Gender-men, n (%) 353 (44)
Age (years) 57±14
Height (cm) 165±10
Weight (kg) 91±23
BMI (kg/m2) 33±7
Body surface area (m2) 2±0.3
Overweight, n (%) 232 (29)
Obesity, n (%)
 Grade I 202 (25)
 Grade II 144 (18)
 Grade III 133 (16)
Waist-corrected BMI (kg/m) 36±13
Waist circumference (cm) 106±15
Waist-to-height ratio 0.64±0.1
Dyslipidemia, n (%) 548 (68)
Increased LDL-C, n (%) 255 (32)
Low-HDL-C, n (%) 220 (27)
Increased triglycerides 299 (37)
Treatment, n (%)
 Statin 130 (16)
 ACEI 200 (25)
 ARB 224 (28)
 BB 231 (29)
 CCB 108 (13)
 Diuretic 273 (34)
Systolic blood pressure (mmHg) 146±19
Diastolic blood pressure (mmHg) 87±10
Systemic arterial hypertension, n (%) 622 (77)
Diabetes mellitus, n (%) 123 (15)
Renal chronic disease, n (%) 154 (19)
History of smoking, n (%) 280 (35)

Ecographic characteristics

LV diastolic diameter (mm) 48±4
LV systolic diameter (mm) 30±4
LV diastolic diameter/height (mm/m) 29±2
LV end-diastolic volume (ml) 112±24
LV end-systolic volume (ml) 37±13
Interventricular septum (mm) 12±1
Infero-lateral wall (mm) 11±1
RWT 0.47±0.6
LVM (g) 212±50
LVMi (g/m2.7) 54±12
LV ejection fraction (%) 62±4
LA volume (ml) 41±15
LA volume/height (ml/m) 0.24±0.09
Septal E/E’ ratio 8.3±2.7
Beta stiffness index 7.7±3
IMT (mm) 0.9±0.2

ACEI=Angiotensin converting enzyme inhibitors, ARB=Angiotensin receptor blockers, BB=Beta blocker, CCB=Calcium channel blocker, LV=Left ventricle, RWT=Relative wall thickness, LVM=Left ventricular mass, LA=Left atrial, LVMi=LVM index, BMI=Body mass index, LDL-C=Low-density lipoprotein cholesterol, HDL-C=High-density lipoprotein cholesterol